AML and MDS associated with PARP inhibitor treatment of ovarian cancer.

Gynecol Oncol

Johns Hopkins Kimmel Cancer Center, Skip Viragh Outpatient Cancer Building, 201 N Broadway, Room 10293, Baltimore, MD 21287, United States of America. Electronic address:

Published: April 2023

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2022.11.027DOI Listing

Publication Analysis

Top Keywords

aml mds
4
mds associated
4
associated parp
4
parp inhibitor
4
inhibitor treatment
4
treatment ovarian
4
ovarian cancer
4
aml
1
associated
1
parp
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!